These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DNA methylation of microRNA genes in multiple myeloma. Wong KY; Huang X; Chim CS Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154 [TBL] [Abstract][Full Text] [Related]
4. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles. Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352 [TBL] [Abstract][Full Text] [Related]
5. miRNA deregulation in multiple myeloma. Bi CL; Chng WJ Chin Med J (Engl); 2011 Oct; 124(19):3164-9. PubMed ID: 22040573 [TBL] [Abstract][Full Text] [Related]
6. The role of circulating miRNAs in multiple myeloma. Zhang J; Xiao X; Liu J Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481 [TBL] [Abstract][Full Text] [Related]
7. The potential of miRNAs as biomarkers for multiple myeloma. Rocci A; Hofmeister CC; Pichiorri F Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410 [TBL] [Abstract][Full Text] [Related]
8. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways. Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022 [TBL] [Abstract][Full Text] [Related]
9. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF. Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180 [TBL] [Abstract][Full Text] [Related]
11. MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma. Campo S; Allegra A; D'Ascola A; Alonci A; Scuruchi M; Russo S; Avenoso A; Gerace D; Campo GM; Musolino C Br J Haematol; 2014 Jun; 165(6):801-13. PubMed ID: 24620752 [TBL] [Abstract][Full Text] [Related]
12. [Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma]. Handa H Rinsho Ketsueki; 2015 Aug; 56(8):981-8. PubMed ID: 26345556 [TBL] [Abstract][Full Text] [Related]
13. Functional Analysis of microRNA in Multiple Myeloma. Di Martino MT; Amodio N; Tassone P; Tagliaferri P Methods Mol Biol; 2016; 1375():181-94. PubMed ID: 25971914 [TBL] [Abstract][Full Text] [Related]
14. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma. Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma. Wong KY; Chim CS Epigenomics; 2015; 7(6):985-1001. PubMed ID: 26417914 [TBL] [Abstract][Full Text] [Related]
16. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma. Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042 [TBL] [Abstract][Full Text] [Related]
17. miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression. Seckinger A; Meißner T; Moreaux J; Benes V; Hillengass J; Castoldi M; Zimmermann J; Ho AD; Jauch A; Goldschmidt H; Klein B; Hose D Oncotarget; 2015 Nov; 6(36):39165-83. PubMed ID: 26472281 [TBL] [Abstract][Full Text] [Related]
18. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Gutiérrez NC; Sarasquete ME; Misiewicz-Krzeminska I; Delgado M; De Las Rivas J; Ticona FV; Fermiñán E; Martín-Jiménez P; Chillón C; Risueño A; Hernández JM; García-Sanz R; González M; San Miguel JF Leukemia; 2010 Mar; 24(3):629-37. PubMed ID: 20054351 [TBL] [Abstract][Full Text] [Related]
19. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression. Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs: potential biomarkers for common malignancies. Khoury S; Tran N Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]